Gritstone Oncology - 48 Year Dividend History | GRTS
Historical dividend payout and yield for Gritstone Oncology (GRTS) since 1971. The current TTM dividend payout for Gritstone Oncology (GRTS) as of June 18, 2019 is $0.00. The current dividend yield for Gritstone Oncology as of June 18, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars - first, a proprietary machine learning-based platform, Gritstone EDGE(TM), which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient?s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients? TSNA to drive the patient?s immune system to attack and destroy tumors.